Contribution of Sigma Receptor Activation to Neuropathic Pain

Sigma 受体激活对神经病理性疼痛的影响

基本信息

  • 批准号:
    7739027
  • 负责人:
  • 金额:
    $ 14.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-07-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application proposes a program of training and research to expand the candidate's future prospects in achieving independence in pain research. The candidate has demonstrated his dedication to research and his initiative and high productivity in prior investigations, but he requires familiarity with a broader range of experimental approaches to fully explore pain pathophysiology and to be competitive in independent funding. The mentor. Dr. Hogan is a well-established clinician/scientist, and the dynamic research surrounding at Medical College of Wisconsin provides an ideal environment for the candidate to become a highly productive independent researcher. The program will help the candidate to accomplish the following goals: 1) establish modern scientific knowledge, acquire the newest research skills, and refine critical analytical abilities; 2) provide coursework and interactive settings that will expand independence as a scientist; 3) apply this new knowledge to examine the role of sigma receptors (aR) in traumatic painful neuropathy and inflammatory pain. Sensory neurons, including their somata in the dorsal root ganglion (DRG), develop abnormal function following nerve trauma and inflammation that contributes to pain. Although numerous triggers have been proposed for initiating these debilitating conditions, none has been established as a clinically relevant pathway. The proposed studies will examine the central hypothesis that activation of alR receptors in nociceptive sensory neurons contributes to neuropathic and inflammatory pain through inhibition of calcium signaling. Specific Aim 1 will determine the effects of olR ligands on behavioral hyperalgesia after nerve injury and injection of complete Freund's adjuvant. Specific Aim 2 will define the expression of olR in primary sensory neurons under baseline conditions. Specific Aim 3 will examine functional consequences of olR activation in vitro, including effects on inward Ca2+ currents, neuronal excitability, and intracellular Ca2+ signaling. Specific Aim 4 will identify expression and functional contributions of alR activity to changes after nerve injury and inflammation. These proposed experiments will employ convergent approaches including molecular and cell biological methods, immunohistochemical and live cell imaging, electrophysiological recording, and behavioral evaluation. The program will establish the candidate's new expertise in electrophysiology, molecular biology, and neuropharmacology and provide the foundation for establishing an independent research program considering olR in pain, opioid tolerance, and addiction. PUBLIC HEALTH RELEVANCE: Exploration of the contributions of alR in primary sensory neurons to pain sensation may provide a new therapeutic pathway for pain conditions that are resistant to currently available treatments.
描述(由申请人提供):这份申请提出了一个培训和研究计划,以扩大候选人在疼痛研究中实现独立的未来前景。候选人在先前的研究中表现出了他对研究的奉献精神、主动性和高生产率,但他需要熟悉更广泛的实验方法,以充分探索疼痛病理生理学,并在独立资助方面具有竞争力。的导师。Hogan博士是一位成熟的临床医生/科学家,威斯康星医学院充满活力的研究环境为候选人成为一名高效的独立研究人员提供了理想的环境。该计划将帮助候选人实现以下目标:1)建立现代科学知识,掌握最新的研究技能,并完善批判性分析能力;2)提供课程作业和互动环境,以扩大科学家的独立性;3)应用这一新知识来研究sigma受体(aR)在创伤性疼痛性神经病变和炎症性疼痛中的作用。感觉神经元,包括它们在背根神经节(DRG)的躯体,在神经创伤和炎症导致疼痛后会出现异常功能。虽然已经提出了许多引发这些衰弱状况的触发因素,但没有一个被确立为临床相关的途径。这些研究将检验一个中心假设,即痛觉感觉神经元中alR受体的激活通过抑制钙信号传导导致神经性和炎症性疼痛。特异性目的1将确定olR配体对神经损伤和注射完全弗氏佐剂后行为痛觉过敏的影响。特异性Aim 2将定义基线条件下初级感觉神经元中olR的表达。特异性目的3将检查体外olR激活的功能后果,包括对内向Ca2+电流、神经元兴奋性和细胞内Ca2+信号的影响。特异性目标4将确定alR活性在神经损伤和炎症后变化中的表达和功能贡献。这些拟议的实验将采用融合的方法,包括分子和细胞生物学方法,免疫组织化学和活细胞成像,电生理记录和行为评估。该项目将建立候选人在电生理学、分子生物学和神经药理学方面的新专业知识,并为建立一个考虑olR在疼痛、阿片类药物耐受性和成瘾方面的独立研究项目提供基础。公共卫生相关性:探索初级感觉神经元中alR对疼痛感觉的贡献可能为目前可用治疗方法抵抗的疼痛状况提供新的治疗途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HSIANG-EN WU其他文献

HSIANG-EN WU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HSIANG-EN WU', 18)}}的其他基金

Contribution of Sigma Receptor Activation to Neuropathic Pain
Sigma 受体激活对神经病理性疼痛的影响
  • 批准号:
    8099763
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:
Contribution of Sigma Receptor Activation to Neuropathic Pain
Sigma 受体激活对神经病理性疼痛的影响
  • 批准号:
    8305717
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:
Contribution of Sigma Receptor Activation to Neuropathic Pain
Sigma 受体激活对神经病理性疼痛的影响
  • 批准号:
    8512682
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:
Contribution of Sigma Receptor Activation to Neuropathic Pain
Sigma 受体激活对神经病理性疼痛的影响
  • 批准号:
    7904928
  • 财政年份:
    2009
  • 资助金额:
    $ 14.28万
  • 项目类别:

相似海外基金

How Spinal Afferent Neurons Control Appetite and Thirst
脊髓传入神经元如何控制食欲和口渴
  • 批准号:
    DP220100070
  • 财政年份:
    2023
  • 资助金额:
    $ 14.28万
  • 项目类别:
    Discovery Projects
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 14.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
  • 批准号:
    10315571
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
  • 批准号:
    10477437
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
  • 批准号:
    10680037
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
  • 批准号:
    10654779
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Neurobiology of Intrinsic Primary Afferent Neurons
内在初级传入神经元的神经生物学
  • 批准号:
    10275133
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
GPR35 on Vagal Afferent Neurons as a Peripheral Drug Target for Treating Diet-Induced Obesity
迷走神经传入神经元上的 GPR35 作为治疗饮食引起的肥胖的外周药物靶点
  • 批准号:
    10470747
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
  • 批准号:
    RGPIN-2014-05517
  • 财政年份:
    2018
  • 资助金额:
    $ 14.28万
  • 项目类别:
    Discovery Grants Program - Individual
Roles of mechanosensory ion channels in myenteric intrinsic primary afferent neurons
机械感觉离子通道在肌间固有初级传入神经元中的作用
  • 批准号:
    RGPIN-2014-05517
  • 财政年份:
    2017
  • 资助金额:
    $ 14.28万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了